Al. Bittencourt et Rn. Takahashi, MAZINDOL AND LIDOCAINE ARE ANTINOCICEPTIVES IN THE MOUSE FORMALIN MODEL - INVOLVEMENT OF DOPAMINE-RECEPTOR, European journal of pharmacology, 330(2-3), 1997, pp. 109-113
The antinociceptive potential of mazindol, an anorectic drug, and lido
caine, an amide-type local anesthetic, were investigated in the mouse
formalin test with concurrent motor function assessment. In addition,
the role of dopamine and opioid receptors in mediation of the antinoci
ceptive action of these drugs was examined. The i.p. injection of mazi
ndol (1.25-10 mg/kg) and lidocaine (10-30 mg/kg) induced significant a
ntinociceptive responses in both phases of the test. Cocaine (20 mg/kg
, i.p.), used as positive control, also inhibited the pain responses c
aused by formalin. Haloperidol (0.2 mg/kg, i.p.), and sulpiride (5 mg/
kg, i.p.), a dopamine D-2 receptor antagonist, reduced the antinocicep
tive actions of mazindol and cocaine, while SCH 23390, R(+)-7-chloro -
hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3 benzazepine (0.03 mg
/kg, i.p.), a dopamine D-2 receptor antagonist, did not affect these r
esponses. Only the antinociception associated with mazindol was revers
ed by naloxone (2 mg/kg, i.p.). The same pretreatments failed to modif
y lidocaine-induced antinociception. The drug conditions used in this
study did not reveal any motor impairment in the rotarod test. These o
bservations suggest an involvement of dopaminergic mechanisms, mainly
via dopamine D-2 receptors, in the antinociceptive action of mazindol
in the formalin test, but the nature of mechanisms involved in the lid
ocaine responses remains unsolved. (C) 1997 Elsevier Science B.V.